Torrent Pharmaceuticals Limited, Ahmedabad, India. Torrent Pharma, a speciality focused pharma company, has strong presence in CV, CNS, GI. Get Torrent Pharmaceuticals Ltd information. Check out Directors, Chairman, CEO and Management information of Torrent Pharmaceuticals Ltd along with.
Torrent Pharmaceuticals Limited is recalling two lots of Losartan potassium tablets, USP.
Trace amounts of an unexpected impurity, N-nitrosodiethylamine (NDEA), which has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.
There have been no reports of adverse events.
The following products, used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and for the treatment of nephropathy in Type 2 diabetic patients, are being recalled:
NDC | Manufacturer | Product Description | Lot/Batch | Expiration Date |
---|---|---|---|---|
13668- 115-30 | Torrent Pharmaceuticals LTD | LOSARTAN POTASSIUM TAB, USP 100mg,30count bottles | BO31C016 | 04/2019 |
13668- 115-90 | Torrent Pharmaceuticals LTD | LOSARTAN POTASSIUM TAB, USP 100mg,90count bottles | BO31C016 | 04/2019 |
13668- 115-10 | Torrent Pharmaceuticals LTD | LOSARTAN POTASSIUM TAB, USP 100mg,1000-count bottles | 4DK3C005 | 04/2019 |
The recalled products were distributed nationwide to Torrent’s wholesale distributor, repackager and retail customers.
What to do
Patients who are on Losartan should continue taking their medication, as the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment.
![Torrent Pharmaceuticals Limited Torrent Pharmaceuticals Limited](/uploads/1/2/5/5/125594043/427769886.jpg)
Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.
Torrent Pharmaceuticals is notifying customers by phone and in writing, arranging for return of all recalled products to Qualanex. Instructions for returning recalled products are given in the recall letter.
Consumers with medical questions or reporting an adverse event may contact Torrent at (800) 912-9561 8:00 am – 5:00 pm (ET), or by email at [email protected]
Questions regarding the return of the recalled product may be be directed to Qualanex at (888) 280-2040 from 8 am - 9:00 pm (ET).
PreviousNext
Not Just Healthcare... Lifecare.
Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 7673 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.
Torrent Pharma has crossed many geographical boundaries with presence in more than 40 countries. The Company is ranked first amongst Indian Companies for having largest market share in Brazil and Germany.
India
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
International
With significant presence in more than 40 countries, Torrent is all poised to spread wings across globe with strong technical capabilities and international accreditations. To enable strategic differentiation, Torrent Pharma’s international business is segregated into US, UK, Germany, Europe, Brazil and Rest of the World.
Therapeutic Areas
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
Search Rx Info
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
Report Adv. Event
Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India. Conceived as a small generic company in the early '70s by Late Shri U N Mehta, Torrent Pharma blazed a new trail in the Indian pharmaceuticals industry by successfully implementing the concept of niche marketing.
800 +
Scientists
Presence in 40 +
Countries
Quarterly Results
Torrent Pharma announces Q1 FY 2019-20 Results click here
Agreement
Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate click here
Quarterly Results
Torrent Pharma announces Q3 FY 2018-19 Results click here
Revenue Q3 FY 18-19
Torrent Pharma reports its Revenue Q3 FY 18-19 click here
Acquisition
Torrent Pharma acquires Bio-Pharm, Inc. click here
Expansion
Torrent & Novo Nordisk India expand insulin manufacturing facility at Indrad click here
Acquisition
Torrent to Acquire Branded Business of India and Nepal from Unichem click here
Archives >>Follow Us On
Torrent Pharmaceuticals Ltd.
CIN: L24230GJ1972PLC002126
Off. Ashram Road, Ahmedabad - 380009, Gujarat, India.
Phone No. : +91-79-26599000 | Fax No: +91-79-26582100
-->